1. RxSight, Inc. faces a class action lawsuit for alleged securities fraud. 2. Lawsuit claims false statements regarding sales and product demand. 3. The class period is between November 2024 and July 2025. 4. Investors can join the lawsuit until September 22, 2025. 5. No out-of-pocket costs for affected investors to participate.
Class action lawsuits typically deter investment; historical cases show significant drops. For instance, when companies like Tesla faced similar lawsuits, their stock prices dropped significantly during the process.
The lawsuit against RxSight highlights potential operational issues, which can significantly influence market perception and investor confidence.
The lawsuit's nature often leads to immediate stock volatility as investors react. Cases can lead to price drops until resolved, often swiftly impacting the perception of value.
NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ:RXST) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of RxSight, Inc. investors who were adversely affected by alleged securities fraud between November 7, 2024 and July 8, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=163442&wire=4
RXST investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Company was experiencing "adoption challenges" and/or structural issues resulting in declines in sales and utilization; (2) defendants had overstated the demand for RxSight's products; (3) as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (4) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
WHAT'S NEXT? If you suffered a loss in RxSight, Inc. during the relevant time frame, you have until September 22, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lost-money-on-rxsight-incrxst-join-class-action-suit-seeking-recovery--contact-levi--korsinsky-302538006.html
SOURCE Levi & Korsinsky, LLP